Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Merge Healthcare, a leading medical imaging solutions provider, today announced that it has reacquired its operations in China.

The sale of Cedara Software Shanghai Co., Ltd (ShanghaiCo) to Inqgen Technology Ltd., initiated by former Merge executives in March 2008 but not finalized, has been terminated by mutual agreement of the parties.

"Earlier in 2008, Merge pursued the divestment of all of its international operations, including China. As we have discussed on our two prior earnings calls, we believe in the growth of our core business on an international scale and therefore terminated the planned divesture of our European operations in June. Now with the reacquisition of our China Operations, we feel that we are well positioned to execute on our global strategy," explains Justin Dearborn, CEO of Merge. "If it is not today, China will soon be the largest market in the world for our products. We feel it is critical to have sales, marketing, customer support and an engineering presence in China to be successful. We are delighted to regain our Chinese operations and customer base as a key element of our international expansion strategy."

Inqgen has participated fully in the transfer to date, working with employees of ShanghaiCo on the communication of transition plans. Zhong Wang, Director, Asia Business Operations of Merge OEM, will immediately be assuming management of the Shanghai operations. "Merge has had success in the recent past in bringing the Cedara toolkits and technologies to the Chinese medical imaging market," states Wang. "I look forward to renewing and expanding these efforts for increased growth and providing a local presence once again."

Source: Merge Healthcare